Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wushouer Ouerkaxi"'
Autor:
Geoffrey W. Stone, Paolo Serafini, Eden Kleiman, Pirouz Daftarian, Marc C. Delcommenne, Mayra Cruz Tleugabulova, Wushouer Ouerkaxi
Publikováno v:
Methods in Pharmacology and Toxicology ISBN: 9781071601709
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a144325bb015136c72e4c43cc7136d1
https://doi.org/10.1007/978-1-0716-0171-6_5
https://doi.org/10.1007/978-1-0716-0171-6_5
Publikováno v:
The Journal of Immunology. 204:165.44-165.44
Background Peptide-MHC (pMHC) tetramers have been widely used in infectious disease and immune-oncology area to detect antigen-specific T cells. However, little is reported about their application in the context of pMHC presentation to stimulate T ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b4cff271602455fc74b5e05e835705a
https://doi.org/10.4049/jimmunol.204.supp.165.44
https://doi.org/10.4049/jimmunol.204.supp.165.44
Autor:
Gloria Sierra, Wushouer Ouerkaxi, Pirouz Daftarian, Jagannadha K Sastry, Marybeth George, Marc Delcommenne
Publikováno v:
The Journal of Immunology. 204:86.17-86.17
HPV cancer treatment outcome has been positively correlated to the presence of patient immunity against the virus. Six HPV strains account for over 75% of cervical cancer cases worldwide with HPVE6 & E7 protein integration into the host’s DNA being
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7e2c9030119f2fa2fd458eb88ec0cc5
https://doi.org/10.4049/jimmunol.204.supp.86.17
https://doi.org/10.4049/jimmunol.204.supp.86.17
Autor:
Wushouer Ouerkaxi, Annie X. An, Ann E. Lin, Marybeth George, Derron Yu, Eunmi Hwang, Amy Yamamura, Mingfa Zang, Pirouz Daftarian, Zhongliang Li, Eden Kleiman, Henry Li
Publikováno v:
Cancer Research. 79:4124-4124
Screening patient peripheral blood using our proposed non-invasive method can boost the accuracy in selecting proper candidates for immune checkpoint therapy in the clinical setting, thereby leading to higher success in treatment. The immune system i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::283e8b93eb5b5cd41902f0a440ede90a
https://doi.org/10.1158/1538-7445.am2019-4124
https://doi.org/10.1158/1538-7445.am2019-4124
Autor:
Pirouz M Daftarian, Wushouer Ouerkaxi
Publikováno v:
The Journal of Immunology. 202:195.35-195.35
Background Many studies have focused on finding a correlation between the responsiveness to immune checkpoint (IC) therapies and the expression level of IC markers. Here, we report the studies on the expression of co-inhibitory molecules on healthy d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5cb83f6edaa5a673cf1563c2d174eaa
https://doi.org/10.4049/jimmunol.202.supp.195.35
https://doi.org/10.4049/jimmunol.202.supp.195.35
Publikováno v:
Cancer Immunology Research. 7:B074-B074
The surge of therapeutic regimens involving immune checkpoint antagonists and co-stimulatory pathways (ACP) antagonists used as single agents or in combination necessitates better functional screening assays. In vitro functional screening assays need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e931f32fa9b4c211b81c25b6f7d9dc46
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-b074
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-b074
Autor:
Pirouz M. Daftarian, Marybeth George, Mayra Cruz Tleugabulova, Dennie Magcase, Wushouer Ouerkaxi, Marc C. Delcommenne
Publikováno v:
The Journal of Immunology. 200:57.49-57.49
A major challenge in the development of immune checkpoint blockades (ICB) is the variability in outcome of such therapeutics. This leads to a large number of non-responder patients receiving costly therapies that are also associated with some toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1586816158f3b7adeb55093869905bb
https://doi.org/10.4049/jimmunol.200.supp.57.49
https://doi.org/10.4049/jimmunol.200.supp.57.49